Kinase General Libraries

Protein kinases are the second most investigated group of drug target after the G-protein-coupled receptors. The majority (67%) of the kinases belong to the serine/threonine protein kinases (STK), and 17% belong to tyrosine protein kinases

Kinase inhibition has been shown to play an essential role in practically all major disease areas. The recent development of small-molecule kinase inhibitors for the treatment of diverse types of cancer has proven to be successful in clinical therapy. Therefore, kinase inhibitor drug discovery programs have recently broadened their focus to include an expanded range of kinase targets and therapeutic areas.

Life Chemicals has carefully selected drug-like screening molecules with predicted kinase-related inhibitory activity from the Life Chemicals HTS Compound Collection, using both ligand-based and receptor-based approaches. The resulting Screening Compound Libraries of potential kinase activity modulators aim to boost kinase-targeted drug discovery efforts.

The compound selection can be customized based on your requirements, cherry picking is available.

Please, contact us at for any additional information and price quotations.

Take advantage of our related services to make your search even more rewarding:
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used. By using our website, you accept our conditions of use of cookies to track data and create content (including advertising) based on your interest. Accept